statnews.com·May 29, 2026
The article highlights recent personnel changes in the pharmaceutical industry, including new hires, promotions, and departures, with a focus on Stefan Irion's appointment as chief scientific officer at GC Therapeutics. It encourages industry insiders to share their own updates for broader dissemination.
The article mentioned that GC Therapeutics has appointed Stefan Irion as Chief Scientific Officer, previously holding the same role at BlueRock Therapeutics. For someone tracking healthtech and biotech, this indicates a strategic move by GC Therapeutics to potentially leverage Irion's expertise and experience in advancing their scientific initiatives, possibly signaling new directions or innovations within the company.